KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [1]
Ontology highlight
ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [1]
PROVIDER: PRJNA471534 | ENA |
REPOSITORIES: ENA
ACCESS DATA